Latest stories
-
What Clinical Trials Really Show About Tigilanol Tiglate from the Blushwood Berry
A viral social media post revived interest in the rainforest drug, but current human trials reveal targeted local results rather than a…
-
Air Pollution Is a Leading Environmental Cause of Early Death, With India Hit Hard
GENEVA, July 18 — Airborne particulate matter is classified as a Group 1 carcinogen, according to the International Agency for Research on…
-
Bedford Artist, 21, Dies of Glioblastoma Weeks After First CT Scan Showed Nothing
WASHINGTON, July 17 — Tyler Morton’s first CT scan did not show the brain lesion that later appeared on a second CT…
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
HONG KONG, July 16 — 2026 marks nearly three decades since Yuk-Ming Dennis Lo first demonstrated the presence of circulating tumor DNA…
-
Drug-Resistant Bacteria: How Antibiotic Success Fed the Superbug Problem
ISLAMABAD, July 8 — The story of antibiotics is one of modern medicine’s greatest triumphs, a narrative of lives snatched back from…
-
Ernexa Moves ERNA-101 Into GMP Manufacturing Ahead of Planned IND Filing
KARACHI, July 15 — Ernexa Therapeutics is moving toward a planned first-in-human Phase 1 study for its lead cancer candidate, ERNA-101, though…
-
Akeso gets FDA and China clearance for Phase II cadonilimab liver cancer trial
BEIJING, July 15 — Akeso’s experimental cancer drug cadonilimab is now being studied in a Phase II clinical trial in the United…
-
How the Dollar Reserve System Drives Global Trade and Finance
BEIJING, July 14 — The 1974 agreement between the United States and Saudi Arabia to price oil exclusively in dollars remains the…
-
Fentanyl Vaccines Move Toward Human Trials as Researchers Try to Stop Overdoses
WASHINGTON, July 13 — A fentanyl vaccine candidate remains in preclinical development, meaning it has not yet entered any human trials overseen…
-
Strand Life Sciences secures patent for blood-based cancer detection technology
NEW DELHI, July 7 — A Bengaluru-based life sciences company has secured a patent from the Indian patent office for a platform…
-
Immunotherapy’s high cost creates divide in cancer care
NEW YORK, July 5 — The figure that matters: $100,000 to $200,000 per patient per year. That is the annual price tag…
-
US Cancer Survival Rose From 49% to 69% Since 1975, but Gains Are Uneven
NEW YORK, July 5 — For families facing a cancer diagnosis, the language of treatment can feel like a foreign country. Words…
-
Vitamin B12 compound shows promise against deadly brain cancer
BOSTON — A modified form of vitamin B12, designed to deliver nitric oxide directly to tumors, has shown promise in early animal…
-
Economist warns mandatory KiwiSaver would remove savers’ exit options
Eric Crampton sees a trap door under compulsory KiwiSaver. The exit ramp vanishes the moment the Government makes saving mandatory. Today, you…
-
AI-designed vaccine passes first human trial, targets multiple coronaviruses
/ HTML. So we can have headings and paragraphs . Must not add new info. Must keep facts: AI-designed vaccine from University…
-
Scripps Team Finds Protein Switch Behind Alzheimer’s Brain Inflammation in Mice
A specific chemical alteration to a single protein may be the mechanism that sustains destructive brain inflammation in Alzheimer’s disease, according to…
-
BA.3.2 Covid subvariant first found in South Africa has since spread to more than 20 countries
Scientists analyzing a specimen collected in South Africa on 22 November 2024 identified a new SARS‑CoV‑2 subvariant, designated BA.3.2. The lineage is…
-
FDA Approves Vorasidenib, First Systemic Therapy for IDH-Mutated Grade 2 Gliomas
On August 15, 2024, the U.S. Food and Drug Administration authorized the use of vorasidenib—marketed as Voranigo—for patients in the United States…
-
UK E. coli Outbreak Linked to Supermarket Sandwiches Kills One, 275 Cases Confirmed
A fatal E. coli outbreak in the United Kingdom has resulted in one death and 67 hospitalizations as of June 27, 2024.…
-
Crisis Text Line Nears 9 Million Conversations in First Decade of Text-Based Crisis Support
Since its founding in 2013, Crisis Text Line has facilitated 9 million conversations, a milestone the organization announced in March 2024. The…
-
WHO Seeks Data on Mysterious Pneumonia Outbreak in Northern China
The World Health Organization has requested information from Chinese authorities regarding a surge in pediatric pneumonia cases in northern China, marking a…
-
US Approves New Multiple Myeloma Treatment Option Elrexfio Medication
On 15 August 2023, U.S. health authorities granted approval to a new therapy for multiple myeloma, a blood‑cancer that remains difficult to…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992






















